In our study, in the subgroup analysis, MECPP was associated with CVD among CKD patients with eGFR 60–90 mL/min/1.73m2, while MBP exhibited association with CVD among CKD patients with eGFR < 60 mL/min/1.73m2. This evidence concerns the gene MBP and chronic kidney disease.